Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $24,117 | 1,340 | 99.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $127.27 | 8 | 0.5% |
| Education | $7.68 | 3 | 0.0% |
| Gift | $0.03 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,126 | 94 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,662 | 95 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $1,254 | 58 | $0 (2022) |
| Eisai Inc. | $1,051 | 47 | $0 (2024) |
| SCILEX PHARMACEUTICALS INC. | $1,020 | 63 | $0 (2024) |
| UCB, Inc. | $844.15 | 66 | $0 (2024) |
| Daiichi Sankyo Inc. | $828.81 | 55 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $772.96 | 45 | $0 (2022) |
| Neurelis, Inc. | $772.22 | 28 | $0 (2024) |
| Allergan, Inc. | $756.69 | 53 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,009 | 140 | ABBVIE INC. ($576.13) |
| 2023 | $2,610 | 129 | ABBVIE INC. ($665.46) |
| 2022 | $2,575 | 141 | ABBVIE INC. ($446.53) |
| 2021 | $3,224 | 173 | Horizon Therapeutics plc ($421.34) |
| 2020 | $2,314 | 137 | Allergan, Inc. ($336.86) |
| 2019 | $4,150 | 227 | Novartis Pharmaceuticals Corporation ($535.37) |
| 2018 | $3,526 | 215 | Daiichi Sankyo Inc. ($410.24) |
| 2017 | $2,844 | 192 | Supernus Pharmaceuticals, Inc. ($295.46) |
All Payment Transactions
1,354 individual payment records from CMS Open Payments — Page 1 of 55
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $26.08 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Azurity Pharmaceuticals, Inc. | ZONISADE (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 12/09/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: EPILEPSY | ||||||
| 12/09/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $25.91 | General |
| Category: EPILEPSY | ||||||
| 12/02/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $14.47 | General |
| Category: NEUROLOGY | ||||||
| 11/26/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 11/18/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: EPILEPSY | ||||||
| 11/15/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Musculoskeletal | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.64 | General |
| 11/06/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: Neurology | ||||||
| 11/05/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/28/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Analgesic | ||||||
| 10/24/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $32.22 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: EPILEPSY | ||||||
| 10/16/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $33.47 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Analgesic | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $28.52 | General |
| Category: Neurology | ||||||
| 10/01/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/01/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $3.63 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 3,717 | 5,535 | $812,073 | $508,559 |
| 2022 | 33 | 3,310 | 6,369 | $727,231 | $486,556 |
| 2021 | 33 | 3,017 | 6,283 | $783,635 | $452,119 |
| 2020 | 32 | 3,149 | 4,507 | $557,498 | $352,690 |
All Medicare Procedures & Services
132 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2023 | 363 | 366 | $128,100 | $94,154 | 73.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 414 | 858 | $102,287 | $67,724 | 66.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 344 | 350 | $105,000 | $51,088 | 48.7% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 131 | 140 | $70,637 | $50,223 | 71.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 365 | 497 | $72,868 | $50,126 | 68.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 215 | 522 | $78,462 | $47,507 | 60.5% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 177 | 198 | $59,763 | $31,373 | 52.5% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 58 | 435 | $24,047 | $17,456 | 72.6% |
| 92546 | Test for abnormal eye movement using a rotating chair | Office | 2023 | 116 | 117 | $19,141 | $14,058 | 73.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 59 | 241 | $17,663 | $12,050 | 68.2% |
| 92540 | Evaluation and testing for balance with recording | Office | 2023 | 116 | 117 | $16,951 | $11,186 | 66.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 92 | 92 | $13,395 | $9,536 | 71.2% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 43 | 49 | $7,840 | $7,520 | 95.9% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 28 | 28 | $11,200 | $5,386 | 48.1% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 45 | 102 | $18,240 | $5,330 | 29.2% |
| 95924 | Testing of autonomic (sympathetic and parasympathetic) nervous system function, at least 5 minutes of tilt | Office | 2023 | 33 | 34 | $8,500 | $4,834 | 56.9% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 16 | 16 | $9,600 | $4,129 | 43.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $6,188 | $4,058 | 65.6% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 33 | 34 | $8,500 | $3,886 | 45.7% |
| 92537 | Test to assess balance during warm and cool irrigation in both ears | Office | 2023 | 80 | 81 | $4,931 | $2,975 | 60.3% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | Office | 2023 | 11 | 11 | $5,500 | $2,759 | 50.2% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 33 | 34 | $8,500 | $2,666 | 31.4% |
| 82306 | Vitamin d-3 level | Office | 2023 | 74 | 78 | $3,900 | $2,263 | 58.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 84 | 90 | $2,250 | $1,181 | 52.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 89 | 97 | $1,940 | $1,004 | 51.8% |
About Dr. Ranga Krishna, M.D
Dr. Ranga Krishna, M.D is a Neurology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730151218.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ranga Krishna, M.D has received a total of $24,252 in payments from pharmaceutical and medical device companies, with $3,009 received in 2024. These payments were reported across 1,354 transactions from 95 companies. The most common payment nature is "Food and Beverage" ($24,117).
As a Medicare-enrolled provider, Krishna has provided services to 13,193 Medicare beneficiaries, totaling 22,694 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 132 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Neuromusculoskeletal Medicine & OMM
- Location Brooklyn, NY
- Active Since 02/07/2006
- Last Updated 09/11/2012
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1730151218
Products in Payments
- UBRELVY (Drug) $1,133
- QULIPTA (Drug) $1,002
- Fycompa (Drug) $926.15
- TROKENDI XR (Drug) $828.41
- ZTLido (Drug) $811.56
- KESIMPTA (Drug) $803.85
- VALTOCO (Drug) $772.22
- ACTHAR (Biological) $681.34
- Morphabond ER (Drug) $607.62
- APTIOM (Drug) $607.02
- NUPLAZID (Drug) $559.99
- Aimovig (Biological) $515.82
- INGREZZA (Drug) $487.49
- UPLIZNA (Drug) $463.94
- MAYZENT (Drug) $452.06
- EMGALITY (Drug) $419.68
- Briviact (Drug) $400.19
- BOTOX (Biological) $362.31
- MOVANTIK (Drug) $334.70
- PURIFIED CORTROPHIN GEL (Drug) $299.20
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Brooklyn
Karen Blitz-Shabbir, Do, DO
Neurology — Payments: $393,441
Miss. Larisa Syrow, Md, MD
Neurology — Payments: $182,526
Nada Abou-Fayssal, Md, MD
Neurology — Payments: $126,065
Robyn Wolintz, Md, MD
Neurology — Payments: $123,772
Miran Salgado, Md, MD
Neurology — Payments: $101,072
Dr. Dmitriy Grinshpun, M.d, M.D
Neurology — Payments: $96,680